These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16504605)

  • 1. Profiling preparations of recombinant birch pollen allergen Bet v 1a with capillary zone electrophoresis in pentamine modified fused-silica capillaries.
    Punzet M; Ferreira F; Briza P; van Ree R; Malissa H; Stutz H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jul; 839(1-2):19-29. PubMed ID: 16504605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling recombinant major birch pollen allergen Bet v 1a and carbamylated variants with CZE and CIEF.
    Kronsteiner B; Malissa H; Stutz H
    Electrophoresis; 2007 Jul; 28(13):2241-51. PubMed ID: 17538926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of capillary zone electrophoresis and capillary isoelectric focusing separations optimized for the characterization of two recombinant products of the birch pollen allergen Bet v 1a.
    Kronsteiner B; Dullnig V; Stutz H
    Electrophoresis; 2008 Jun; 29(12):2539-49. PubMed ID: 18512676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation and characterization of nitrated variants of the major birch pollen allergen by CZE-ESI-μTOF MS.
    Gusenkov S; Ackaert C; Stutz H
    Electrophoresis; 2013 Sep; 34(18):2695-704. PubMed ID: 23857337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successive multiple ionic polymer layer coated capillaries in the separation of proteins - recombinant allergen variants as a case study.
    Weinbauer M; Stutz H
    Electrophoresis; 2010 Jun; 31(11):1805-12. PubMed ID: 20506417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High throughput screening of mixed-mode sorbents and optimisation using pre-packed lab-scale columns for the purification of the recombinant allergen rBet v 1a.
    Brenac Brochier V; Chabre H; Lautrette A; Ravault V; Couret MN; Didierlaurent A; Moingeon P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2420-7. PubMed ID: 19345650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confirmation of immuno-reactivity of the recombinant major birch pollen allergen Bet v 1a by affinity-CIEF.
    Dullnig V; Weiss R; Amon S; Rizzi A; Stutz H
    Electrophoresis; 2009 Jul; 30(13):2337-46. PubMed ID: 19621361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy.
    Batard T; Didierlaurent A; Chabre H; Mothes N; Bussières L; Bohle B; Couret MN; Ball T; Lemoine P; Focks Tejkl M; Chenal A; Clément G; Dupont F; Valent P; Krauth MT; André C; Valenta R; Moingeon P
    Int Arch Allergy Immunol; 2005 Mar; 136(3):239-49. PubMed ID: 15722633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Top-down and bottom-up characterization of nitrated birch pollen allergen Bet v 1a with CZE hyphenated to an Orbitrap mass spectrometer.
    Gusenkov S; Stutz H
    Electrophoresis; 2018 May; 39(9-10):1190-1200. PubMed ID: 29389018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folded or Not? Tracking Bet v 1 Conformation in Recombinant Allergen Preparations.
    Husslik F; Hanschmann KM; Krämer A; Seutter von Loetzen C; Schweimer K; Bellinghausen I; Treudler R; Simon JC; Vogel L; Völker E; Randow S; Reuter A; Rösch P; Vieths S; Holzhauser T; Schiller D
    PLoS One; 2015; 10(7):e0132956. PubMed ID: 26186356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of natural Bet v 1 from birch pollen and related allergens from carrot and celery.
    Bollen MA; Garcia A; Cordewener JH; Wichers HJ; Helsper JP; Savelkoul HF; van Boekel MA
    Mol Nutr Food Res; 2007 Dec; 51(12):1527-36. PubMed ID: 17979095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic profiling of birch (Betula verrucosa) pollen extracts from different origins.
    Erler A; Hawranek T; Krückemeier L; Asam C; Egger M; Ferreira F; Briza P
    Proteomics; 2011 Apr; 11(8):1486-98. PubMed ID: 21360672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallization and preliminary X-ray investigation at 2.0 A resolution of Bet v 1, a birch pollen protein causing IgE-mediated allergy.
    Spangfort MD; Larsen JN; Gajhede M
    Proteins; 1996 Nov; 26(3):358-60. PubMed ID: 8953655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients.
    Nony E; Bouley J; Le Mignon M; Lemoine P; Jain K; Horiot S; Mascarell L; Pallardy M; Vincentelli R; Leone P; Roussel A; Batard T; Abiteboul K; Robin B; de Beaumont O; Arvidsson M; Rak S; Moingeon P
    Allergy; 2015 Jul; 70(7):795-804. PubMed ID: 25846209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1.
    Gafvelin G; Thunberg S; Kronqvist M; Grönlund H; Grönneberg R; Troye-Blomberg M; Akdis M; Fiebig H; Purohit A; Horak F; Reisinger J; Niederberger V; Akdis CA; Cromwell O; Pauli G; Valenta R; van Hage M
    Int Arch Allergy Immunol; 2005 Sep; 138(1):59-66. PubMed ID: 16103688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model system to study the environment-dependent expression of the Bet v 1a gene encoding the major birch pollen allergen.
    Tashpulatov AS; Clement P; Akimcheva SA; Belogradova KA; Barinova I; Rakhmawaty FD; Heberle-Bors E; Touraev A
    Int Arch Allergy Immunol; 2004 May; 134(1):1-9. PubMed ID: 15051934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bet v 1142-156 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1-related food allergens.
    Jahn-Schmid B; Radakovics A; Lüttkopf D; Scheurer S; Vieths S; Ebner C; Bohle B
    J Allergy Clin Immunol; 2005 Jul; 116(1):213-9. PubMed ID: 15990797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
    Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
    J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular composition and biological activity of commercial birch pollen allergen extracts.
    Focke M; Marth K; Valenta R
    Eur J Clin Invest; 2009 May; 39(5):429-36. PubMed ID: 19302561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of specific IgE antibodies in sera of Japanese birch-allergic patients using recombinant allergens Bet v 1, Bet v 2 and Bet v 4.
    Shirasaki H; Yamamoto T; Koyanagi Y; Watanabe N; Himi T
    Allergol Int; 2008 Mar; 57(1):93-6. PubMed ID: 18209509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.